Rossari Biotech: Q1 EBITDA Rises, But Margins Slip YoY

🧪

posted Q1 EBITDA of ₹680 million, up from ₹649 million YoY. However, EBITDA margin declined to 12.51% from 13.25%, reflecting a dip in profitability despite higher earnings.